InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Browse the complete record of transactions filed by Pauwels Eric, Directeur Commercial. Officer active across 1 company, notably PTC Therapeutics, INC.. Aggregated, 9 reports have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €201k. History available since 4 January 2022. The latest transaction was filed on 19 April 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
822 shares@ US$42.5150.0005% mcap16.1% of flowCommon StockSEC:0001415889-22-004210:0
367 shares@ US$40.0020.0002% mcap6.5% of flowCommon StockSEC:0001179110-22-000839:0
367 shares@ US$40.0020.0002% mcap15.5% of flowCommon StockSEC:0001179110-22-000839
359 shares@ US$39.3140.0002% mcap6.2% of flowCommon StockSEC:0001179110-22-000630:0
359 shares@ US$39.3140.0002% mcap14.8% of flowCommon StockSEC:0001179110-22-000630
866 shares@ US$38.5250.0005% mcap35.0% of flowCommon StockSEC:0001179110-22-000395
866 shares@ US$38.5250.0005% mcap14.7% of flowCommon StockSEC:0001179110-22-000395:0
806 shares@ US$41.1620.0005% mcap34.8% of flowCommon StockSEC:0001179110-22-000301
806 shares@ US$41.1620.0005% mcap14.6% of flowCommon StockSEC:0001179110-22-000301:0
9 of 9 declarations
About Pauwels Eric
Eric Pauwels is the Chief Business Officer at PTC Therapeutics, Inc. He oversees the company's business and strategic initiatives, contributing to its development and growth in the market.
